主动脉夹层、壁内血肿和穿透性主动脉溃疡患者长期主动脉增长与疾病进展的预测因素
基于罗切斯特流行病学项目队列,纳入1995至2015年奥姆斯特德县新诊断主动脉夹层、壁内血肿或穿透性主动脉溃疡且有足够影像数据的患者,分析长期主动脉直径变化与疾病进展的预测因素。中位随访8.1年,多数患者出现主动脉增长和临床疾病进展,自发消退不常见,症状性表现、结缔组织病、初始直径>42 mm、PAU深度>10 mm等与增长或进展相关。
要点
- 主动脉夹层患者中87%出现主动脉直径增长,中位1.0 mm/年,10年无疾病进展率仅22%。
- 壁内血肿和穿透性主动脉溃疡的10年无疾病进展率分别为44%和46%。
- DeBakey I/IIIB型夹层、初始IMH直径、PAU深度>10 mm与疾病进展相关。
核心结论
- 多数主动脉综合征患者可观察到主动脉增长和临床疾病进展,而自发消退不常见。
- 主动脉增长和疾病进展的预测因素可用于制定合适的随访计划和最终早期干预。
研究设计与样本
- 使用罗切斯特流行病学项目记录链接系统,识别1995至2015年明尼苏达州奥姆斯特德县新诊断主动脉夹层、壁内血肿和穿透性主动脉溃疡的居民。
- 133例 incident 病例中,46例主动脉夹层、12例壁内血肿和28例穿透性主动脉溃疡有足够影像数据被纳入分析。
- 总体中位随访时间为8.1年。
主要发现
- 主动脉直径增长见于40例主动脉夹层(87%,中位1.0 mm/年)、5例壁内血肿(42%,中位0.2 mm/年)和14例穿透性主动脉溃疡(50%,中位0.4 mm/年)。
- 症状性表现(P = 0.045)、结缔组织病(P = 0.005)和初始主动脉直径>42 mm(P = 0.013)与主动脉夹层增长速率相关。
- 穿透性主动脉溃疡深度>9 mm(P = 0.047)和女性(P = 0.013)与穿透性主动脉溃疡和壁内血肿的主动脉增长速率相关。
- 10年无疾病进展率:主动脉夹层22%(95% CI 12-41),壁内血肿44%(95% CI 22-92),穿透性主动脉溃疡46%(95% CI 27-78)。
- DeBakey I/IIIB型主动脉夹层(HR 3.09;P = 0.038)、初始壁内血肿主动脉直径(HR 1.4;P = 0.037)和穿透性主动脉溃疡深度>10 mm(HR 3.92;P = 0.018)与疾病进展相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We aimed to identify predictors of long-term aortic diameter change and disease progression in a population cohort of patients with newly diagnosed aortic dissection (AD), intramural hematoma (IMH), or penetrating aortic ulcer (PAU). METHODS: We used the Rochester Epidemiology Project record linkage system to identify all Olmsted County, MN-USA, residents diagnosed with AD, IMH, and PAU (1995-2015). The endpoints were aortic diameter change, freedom from clinical disease progression (any related intervention, aortic aneurysm, new aortic syndrome, rupture or death) and disease resolution (complete spontaneous radiological disappear). Linear regression was used to assess aortic growth rate; predictors of disease progression were identified with Cox proportional hazards. RESULTS: Of 133 incident cases, 46 ADs, 12 IMHs, and 28 PAUs with sufficient imaging data were included. Overall median follow-up was 8.1 years. Aortic diameter increase occurred in 40 ADs (87%, median 1.0 mm/year), 5 IMHs (42%, median 0.2 mm/year) and 14 PAUs (50%, median 0.4 mm/year). Symptomatic presentation (P = 0.045), connective tissue disorders (P = 0.005), and initial aortic diameter >42 mm (P = 0.013) were associated with AD growth rate. PAU depth >9 mm (P = 0.047) and female sex (P = 0.013) were associated with aortic growth rate in PAUs and IMHs. At 10 years, freedom from disease progression was 22% (95% CI 12-41) for ADs, 44% (95% CI 22-92) for IMHs, and 46% (95% CI 27-78) for PAUs. DeBakey I/IIIB AD (HR 3.09; P = 0.038), initial IMH aortic diameter (HR 1.4; P = 0.037) and PAU depth >10 mm (HR 3.92; P = 0.018) were associated with disease progression. No AD spontaneously resolved; resolution rate at 10 years was 22% (95% CI 0-45) for IMHs and 11% (95% CI 0-23) for PAUs. CONCLUSIONS: Aortic growth and clinical disease progression are observed in most patients with aortic syndromes, while spontaneous resolution is uncommon. Predictors of aortic growth and disease progression may be used to tailor appropriate follow-up and eventual early intervention.
引用
- Squizzato F, Hyun MC, Sen I, et al. Predictors of Long-Term Aortic Growth and Disease Progression in Patients with Aortic Dissection, Intramural Hematoma, and Penetrating Aortic Ulcer. Ann Vasc Surg. 2021. PMID: 34785342. doi:10.1016/j.avsg.2021.10.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。